FDA Overreach Threatens Business with Unnecessary Ban on Red Dye No. 3

The FDA's decision to ban Red Dye No. 3 represents another example of governmental overreach, placing undue burden on food industry businesses already struggling with regulatory compliance. By allowing a grace period until January 2027 for the sale of existing stock, the FDA inadvertently acknowledges the impracticality of its mandate, undermining the scientific and economic rationale for such bans and illustrating the need for a more balanced approach to regulation that considers the impacts on innovation and the economy.